Carvedilol and Hydrochlorothiazide in Hypertensives with Metabolic Disorder: Not Always Bad News - An Austrian Survey

Zweiker R, Perl S, Sock S, Stoschitzky K, Plank J, Kvas E
Carvedilol and Hydrochlorothiazide in Hypertensives with Metabolic Disorder: Not Always Bad News - An Austrian Survey
Journal für Hypertonie - Austrian Journal of Hypertension 2009; 13 (2): 22-26

Volltext (PDF) Summary Praxisrelevanz Übersicht

Abbildung 3: HbA1c
HbA1c levels (mg %); baseline visit (VO) to visit after 1 year (V4).

Abbildung 3: HbA1c
HbA1c levels (mg %); baseline visit (VO) to visit after 1 year (V4).